Sage Therapeutics (SAGE) Short Interest Ratio & Short Volume $7.30 +0.15 (+2.03%) As of 02:15 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Sage Therapeutics Short Interest DataSage Therapeutics (SAGE) has a short interest of 4.17 million shares, representing 7.75% of the float (the number of shares available for trading by the public). This marks a -31.97% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.4, indicating that it would take 2.4 days of the average trading volume of 2.34 million shares to cover all short positions.Current Short Interest4,170,000 sharesPrevious Short Interest6,130,000 sharesChange Vs. Previous Month-31.97%Dollar Volume Sold Short$30.23 millionShort Interest Ratio2.4 Days to CoverLast Record DateJanuary 31, 2025Outstanding Shares61,480,000 sharesFloat Size53,820,000 sharesShort Percent of Float7.75%Today's Trading Volume986,678 sharesAverage Trading Volume2,337,437 sharesToday's Volume Vs. Average42% Short Selling Sage Therapeutics? Sign up to receive the latest short interest report for Sage Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSAGE Short Interest Over TimeSAGE Days to Cover Over TimeSAGE Percentage of Float Shorted Over Time Sage Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/20254,170,000 shares $30.23 million -32.0%7.8%2.4 $7.25 1/15/20256,130,000 shares $44.50 million +26.9%11.7%3.9 $7.26 12/31/20244,830,000 shares $26.23 million -24.7%9.0%4.7 $5.43 12/15/20246,410,000 shares $34.52 million -1.8%11.9%6.8 $5.39 11/30/20246,530,000 shares $35.72 million +1.9%12.1%8.8 $5.47 11/15/20246,410,000 shares $32.69 million +6.8%11.9%8.8 $5.10 10/31/20246,000,000 shares $36.48 million -1.8%11.9%9 $6.08 10/15/20246,110,000 shares $41.91 million +7.0%12.2%9.1 $6.86 9/30/20245,710,000 shares $41.23 million -1.9%11.4%7.7 $7.22 9/15/20245,820,000 shares $45.57 million -6.4%11.6%7.1 $7.83 Get the Latest News and Ratings for SAGE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sage Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/31/20246,220,000 shares $52.43 million +4.9%12.4%6.2 $8.43 8/15/20245,930,000 shares $49.22 million +7.6%11.8%5.6 $8.30 7/31/20245,510,000 shares $60.33 million -1.1%11.0%4.6 $10.95 7/15/20245,570,000 shares $65.73 million -1.8%11.3%4.5 $11.80 6/30/20245,670,000 shares $61.58 million -27.3%11.5%4.4 $10.86 6/15/20247,800,000 shares $93.60 million +12.2%15.8%6.2 $12.00 5/31/20246,950,000 shares $77.21 million -17.9%14.0%6 $11.11 5/15/20248,460,000 shares $99.07 million +3.8%17.1%7.9 $11.71 4/30/20248,150,000 shares $113.61 million -12.5%16.6%7.8 $13.94 4/15/20249,310,000 shares $142.63 million +8.3%19.0%9.2 $15.32 3/31/20248,600,000 shares $161.16 million +2.4%17.5%9.1 $18.74 3/15/20248,400,000 shares $167.75 million +6.2%17.1%9 $19.97 2/29/20247,910,000 shares $169.91 million -12.3%16.1%8.3 $21.48 2/15/20249,020,000 shares $229.20 million +14.8%18.4%9.8 $25.41 1/31/20247,860,000 shares $201.53 million +10.1%15.3%9.1 $25.64 1/15/20247,140,000 shares $189.57 million -4.0%13.9%8 $26.55 12/31/20237,440,000 shares $161.22 million -10.6%14.5%8.6 $21.67 12/15/20238,320,000 shares $180.21 million -3.8%16.2%9.6 $21.66 11/30/20238,650,000 shares $169.37 million -1.7%16.8%8.4 $19.58 11/15/20238,800,000 shares $169.05 million +2.2%17.1%8.1 $19.21 10/31/20238,610,000 shares $161.27 million -12.8%16.7%7.1 $18.73 10/15/20239,870,000 shares $193.25 million +0.1%19.2%5.6 $19.58 9/30/20239,860,000 shares $202.92 million +3.6%19.2%5.7 $20.58 9/15/20239,520,000 shares $200.11 million +2.7%18.5%5.6 $21.02 8/31/20239,270,000 shares $185.40 million +1.2%18.0%5.9 $20.00 8/15/20239,160,000 shares $194.65 million +27.2%17.8%6.3 $21.25 7/31/20237,200,000 shares $249.70 million +17.5%14.0%5.6 $34.68 7/15/20236,130,000 shares $285.60 million +19.5%12.0%9 $46.59 6/30/20235,130,000 shares $241.21 million -4.8%10.0%8 $47.02 6/15/20235,390,000 shares $302.38 million -0.4%10.5%9.2 $56.10Three new patents reveal Elon and Trump’s secret “Project America” (Ad)Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR! He says these 5 stocks are trading for less than $2 right now… But they could soon SOAR in Trump’s first 100 days.Get the names and tickers now for $1 5/31/20235,410,000 shares $267.80 million -3.6%10.6%10.3 $49.50 5/15/20235,610,000 shares $299.01 million +18.6%10.9%10.6 $53.30 4/30/20234,730,000 shares $231.06 million -2.7%9.2%8.8 $48.85 4/15/20234,860,000 shares $213.69 million +1.5%9.5%9.7 $43.97 3/31/20234,790,000 shares $200.99 million -3.0%9.4%9.3 $41.96 3/15/20234,940,000 shares $214.00 million -4.8%9.7%10 $43.32 2/28/20235,190,000 shares $216.11 million +10.2%10.2%10.5 $41.64 2/15/20234,710,000 shares $212.47 million +2.4%9.2%9.4 $45.11 1/31/20234,600,000 shares $203.96 million +20.1%9.0%9 $44.34 1/15/20233,830,000 shares $174.57 million -8.6%7.5%7.6 $45.58 12/30/20224,190,000 shares $159.81 million +2.7%8.2%8.8 $38.14 12/15/20224,080,000 shares $164.63 million +2.5%8.0%8.4 $40.35 11/30/20223,980,000 shares $163.34 million +7.9%7.8%8.4 $41.04 11/15/20223,690,000 shares $130.07 million -0.5%7.3%8.3 $35.25 10/31/20223,710,000 shares $139.72 million +2.8%7.3%8.5 $37.66 10/15/20223,610,000 shares $136.93 million +0.6%7.1%8 $37.93 9/30/20223,590,000 shares $140.58 million +10.5%7.0%7.9 $39.16 9/15/20223,250,000 shares $137.35 million -9.5%6.4%5.5 $42.26 8/31/20223,590,000 shares $135.20 million +5.6%7.1%5.2 $37.66 8/15/20223,400,000 shares $147.12 million -1.2%6.7%4.5 $43.27 7/31/20223,440,000 shares $118.37 million -3.4%6.8%4.2 $34.41 7/15/20223,560,000 shares $125.49 million -1.9%7.0%4.4 $35.25 6/30/20223,630,000 shares $117.25 million +16.4%7.2%4.3 $32.30 6/15/20223,120,000 shares $101.62 million +9.9%6.2%3.5 $32.57 5/31/20222,840,000 shares $88.81 million -3.4%5.6%4 $31.27 5/15/20222,940,000 shares $90.29 million +1.0%5.8%4.4 $30.71 4/30/20222,910,000 shares $91.72 million +1.8%5.8%4 $31.52 4/15/20222,860,000 shares $100.82 million -6.5%5.7%4.2 $35.25 3/31/20223,060,000 shares $101.29 million -4.7%6.0%4.5 $33.10 3/15/20223,210,000 shares $100.70 million +1.3%6.3%5.4 $31.37 2/28/20223,170,000 shares $115.29 million +18.3%6.3%5.5 $36.37 2/15/20222,680,000 shares $116.58 million -2.6%5.3%4.7 $43.50 1/31/20222,750,000 shares $108.41 million +1.1%5.4%5.9 $39.42 1/15/20222,720,000 shares $116.77 million -1.8%5.3%5.7 $42.93 12/31/20212,770,000 shares $117.84 million -3.2%5.4%5.9 $42.54 12/15/20212,860,000 shares $113.57 million +2.9%5.5%6.1 $39.71 11/30/20212,780,000 shares $108.17 million +2.2%5.4%6 $38.91 11/15/20212,720,000 shares $112.72 million +2.6%5.3%5.9 $41.44 10/29/20212,650,000 shares $106.95 million +6.0%5.1%5.4 $40.36 10/15/20212,500,000 shares $112.35 million +6.8%4.9%4.6 $44.94 9/30/20212,340,000 shares $103.69 million +23.8%4.5%3.9 $44.31 9/15/20211,890,000 shares $85.01 million -16.4%3.7%2.9 $44.98 8/31/20212,260,000 shares $104.43 million -13.1%4.4%2.4 $46.21 8/13/20212,600,000 shares $113.00 million -23.5%5.1%2.8 $43.46 7/30/20213,400,000 shares $148.68 million -8.9%6.6%3.7 $43.73 7/15/20213,730,000 shares $179.97 million -3.1%7.3%4.4 $48.25 6/30/20213,850,000 shares $218.72 million -7.2%7.5%4.8 $56.81 6/15/20214,150,000 shares $244.02 million -1.0%8.1%5.6 $58.80 5/28/20214,190,000 shares $291.62 million -2.3%8.2%8.9 $69.60 5/14/20214,290,000 shares $297.94 million -4.0%N/A8.8 $69.45Three new patents reveal Elon and Trump’s secret “Project America” (Ad)Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR! He says these 5 stocks are trading for less than $2 right now… But they could soon SOAR in Trump’s first 100 days.Get the names and tickers now for $1 4/30/20214,470,000 shares $352.59 million +1.4%N/A9.3 $78.88 4/15/20214,410,000 shares $333.70 million -2.4%N/A9.1 $75.67 3/31/20214,520,000 shares $331.23 million -11.4%N/A9.1 $73.28 3/15/20215,100,000 shares $401.47 million -1.9%N/A9.7 $78.72 2/26/20215,200,000 shares $433.94 million +2.0%N/A9.4 $83.45 2/12/20215,100,000 shares $426.05 million -1.0%10.0%7.9 $83.54 1/29/20215,150,000 shares $408.24 million -2.7%10.3%7.8 $79.27 1/15/20215,290,000 shares $511.86 million +0.6%10.5%7.8 $96.76 12/31/20205,260,000 shares $466.35 million -0.9%N/A7.5 $88.66 12/15/20205,310,000 shares $375.31 million -2.4%10.6%7.4 $70.68 11/30/20205,440,000 shares $411.10 million +1.7%10.8%7.2 $75.57 11/15/20205,350,000 shares $425.43 million -1.1%10.7%8.4 $79.52 10/30/20205,410,000 shares $399.85 million +6.1%10.8%8.6 $73.91 10/15/20205,100,000 shares $325.84 million -17.9%10.2%7.7 $63.89 9/30/20206,210,000 shares $379.56 million -14.5%12.4%9.4 $61.12 9/15/20207,260,000 shares $424.86 million -3.8%14.5%10.6 $58.52 8/31/20207,550,000 shares $395.92 million +3.9%15.0%10.9 $52.44 8/14/20207,270,000 shares $363.50 million -2.4%14.5%9.9 $50.00 7/31/20207,450,000 shares $339.50 million +3.9%14.6%9.1 $45.57 7/15/20207,170,000 shares $312.97 million +0.3%14.1%8.1 $43.65 6/30/20207,150,000 shares $298.66 million +8.3%14.0%6.7 $41.77 6/15/20206,600,000 shares $238.99 million +0.9%13.0%5.6 $36.21 5/29/20206,540,000 shares $233.61 million +0.5%12.9%5.1 $35.72 5/15/20206,510,000 shares $240.48 million -6.7%12.8%4.8 $36.94 4/30/20206,980,000 shares $272.08 million -1.1%13.7%5.5 $38.98 4/15/20207,060,000 shares $202.62 million +4.0%13.9%5.8 $28.70 3/31/20206,790,000 shares $258.77 million +1.3%13.3%6.3 $38.11 3/13/20206,702,500 shares $194.57 million +2.2%13.2%5.7 $29.03 2/28/20206,560,000 shares $171.54 million -1.7%12.9%5.9 $26.15 SAGE Short Interest - Frequently Asked Questions What is Sage Therapeutics' current short interest? Short interest is the volume of Sage Therapeutics shares that have been sold short but have not yet been covered or closed out. As of January 31st, investors have sold 4,170,000 shares of SAGE short. 7.75% of Sage Therapeutics' shares are currently sold short. Learn More on Sage Therapeutics' current short interest. What is a good short interest ratio for Sage Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SAGE shares currently have a short interest ratio of 2.0. Learn More on Sage Therapeutics's short interest ratio. Which institutional investors are shorting Sage Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Sage Therapeutics: Group One Trading LLC, Citadel Advisors LLC, Concourse Financial Group Securities Inc., and JPMorgan Chase & Co.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Sage Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.75% of Sage Therapeutics' floating shares are currently sold short. Is Sage Therapeutics' short interest increasing or decreasing? Sage Therapeutics saw a drop in short interest in January. As of January 31st, there was short interest totaling 4,170,000 shares, a drop of 32.0% from the previous total of 6,130,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Sage Therapeutics' float size? Sage Therapeutics currently has issued a total of 61,480,000 shares. Some of Sage Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Sage Therapeutics currently has a public float of 53,820,000 shares. How does Sage Therapeutics' short interest compare to its competitors? 7.75% of Sage Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Sage Therapeutics: Vera Therapeutics, Inc. (16.56%), Iovance Biotherapeutics, Inc. (26.04%), Praxis Precision Medicines, Inc. (15.21%), Galapagos NV (2.65%), Wave Life Sciences Ltd. (6.16%), Apogee Therapeutics, Inc. (24.33%), Evotec SE (0.22%), Disc Medicine, Inc. (12.11%), Arcutis Biotherapeutics, Inc. (16.16%), Amphastar Pharmaceuticals, Inc. (11.54%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks. What does it mean to sell short Sage Therapeutics stock? Short selling SAGE is an investing strategy that aims to generate trading profit from Sage Therapeutics as its price is falling. SAGE shares are trading up $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Sage Therapeutics? A short squeeze for Sage Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SAGE, which in turn drives the price of the stock up even further. How often is Sage Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SAGE, twice per month. The most recent reporting period available is January, 31 2025. More Short Interest Resources from MarketBeat Related Companies Vera Therapeutics Short Interest Data Iovance Biotherapeutics Short Interest Data Praxis Precision Medicines Short Interest Data Galapagos Short Interest Data Wave Life Sciences Short Interest Data Apogee Therapeutics Short Interest Data Evotec Short Interest Data Disc Medicine Short Interest Data Arcutis Biotherapeutics Short Interest Data Amphastar Pharmaceuticals Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SAGE) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sage Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sage Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SAGE Stock Alerts